The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer
Open Access
- 1 March 2013
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 6 (2), 281-292
- https://doi.org/10.1242/dmm.010561
Abstract
Cholangiocarcinoma is a fatal cancer of the biliary epithelium and has an incidence that is increasing worldwide. Survival beyond a year of diagnosis is less than 5%, and therapeutic options are few. Known risk factors include biliary diseases such as primary sclerosing cholangitis and parasitic infestation of the biliary tree, but most cases are not associated with any of these underlying diseases. Numerous in vitro and in vivo models, as well as novel analytical techniques for human samples, are helping to delineate the many pathways implicated in this disease, albeit at a frustratingly slow pace. As yet, however, none of these studies has been translated into improved patient outcome and, overall, the pathophysiology of cholangiocarcinoma is still poorly understood. There remains an urgent need for new approaches and models to improve management of this insidious and devastating disease. In this review, we take a bedside-to-bench approach to discussing cholangiocarcinoma and outline research opportunities for the future in this field.This publication has 139 references indexed in Scilit:
- Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinomaJournal of Hepatology, 2012
- E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinomaBritish Journal of Cancer, 2011
- Clinical diagnosis and staging of cholangiocarcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract CancerJournal of Clinical and Experimental Hepatology, 2011
- Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasizationHepatology, 2011
- Risk factors for cholangiocarcinomaHepatology, 2011
- Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecologic Oncology, 2011
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veteransHepatology, 2008
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatmentHepatology, 2008
- Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphismsHepatology, 2007